AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 34 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,522,000 | +15.5% | 6,100,000 | 0.0% | 0.20% | -6.1% |
| Q2 2020 | $4,783,000 | +1.5% | 6,100,000 | 0.0% | 0.21% | +34.8% |
| Q1 2020 | $4,714,000 | -81.5% | 6,100,000 | -79.8% | 0.16% | -63.2% |
| Q4 2019 | $25,421,000 | -3.3% | 30,125,000 | -5.5% | 0.43% | +11.4% |
| Q3 2019 | $26,297,000 | +1.5% | 31,875,000 | -1.2% | 0.38% | +30.5% |
| Q2 2019 | $25,913,000 | -8.5% | 32,275,000 | -0.6% | 0.30% | -17.1% |
| Q1 2019 | $28,334,000 | -6.3% | 32,475,000 | -1.5% | 0.36% | -14.2% |
| Q4 2018 | $30,227,000 | -12.9% | 32,975,000 | 0.0% | 0.42% | +3.8% |
| Q3 2018 | $34,691,000 | +2.8% | 32,975,000 | 0.0% | 0.40% | -3.6% |
| Q2 2018 | $33,746,000 | -2.7% | 32,975,000 | -1.8% | 0.42% | +3.2% |
| Q1 2018 | $34,667,000 | +20.0% | 33,575,000 | 0.0% | 0.40% | +17.5% |
| Q4 2017 | $28,895,000 | -6.1% | 33,575,000 | +6.3% | 0.34% | +2.7% |
| Q3 2017 | $30,786,000 | -2.0% | 31,575,000 | -3.4% | 0.33% | -2.9% |
| Q2 2017 | $31,409,000 | – | 32,675,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|